FY20 Semi-Annual Report: April 2020—September 2020

The United States Agency for International Development (USAID) granted funding to FHI 360 for the implementation of Act to End Neglected Tropical Disease West (Act | West) program from July 19, 2018–July 18, 2023. The program is part of the global effort to eliminate neglected tropical diseases (NTDs). It particularly aims to eliminate lymphatic filariasis (LF), trachoma, and onchocerciasis (OV) (in certain countries) and control schistosomiasis (SCH) and soil-transmitted helminthiasis (STH) in 11 endemic West African countries—including Burkina Faso, Benin, Cameroon, Guinea, Ghana, Côte D’Ivoire, Mali, Niger, Senegal, Sierra Leone, and Togo. It also supports achievement of sustainable service delivery, with growing ownership of national governments in the elimination and/or control of NTDs. This report outlines the key achievements and challenges in the first six months of the second year of program implementation, spanning the period April 1, 2020–September 30, 2020.

USAID's Act to End NTDs | West Program FY20 Semi-Annual Report 2 Cover
Type
Semi-annual report
Year of publication
Disease
All Preventive Chemotherapy NTDs
Country
All Countries, Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone, Togo
Focus Areas
Mass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Support for NTD Sustainability, Advocacy and policies, Cross-sector collaboration, NTD governance, Strategic health information, NTD Capacity Building, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier development
Partners
AIM Initiative, Deloitte, FHI360, HDI, HKI, World Vision